radiomedix logo
RadioMedix Inc. and AREVA Med Announce Completion of the Exploratory Clinical Trial of 203Pb-AR-RMX in patients expressing somatostatin receptor positive neuroendocrine tumors
June 22, 2017 16:00 ET | RadioMedix Inc.
Houston, TX; Plano, TX, June 22, 2017 (GLOBE NEWSWIRE) --  RadioMedix Inc and AREVA Med announced today the completion of the exploratory clinical trial  evaluating the biodistribution...